Stem Cell Therapy for Early Alzheimer's Disease

This study is testing stem cell therapy for people in the early stages of Alzheimer's disease — specifically those with mild cognitive impairment (early memory and thinking problems linked to Alzheimer's). Researchers want to find out if stem cells can slow or reverse these early changes in the brain. **You may be eligible if...** - You are between 60 and 80 years old - You have been diagnosed with mild cognitive impairment or early Alzheimer's disease - Your cognitive score (MMSE) is 22 or higher (mild impairment range) - You have brain scans or fluid tests showing Alzheimer's-related protein changes (amyloid) - You have elevated blood markers of inflammation (CRP, IL-6, TNF-α) - You have an APOE genetic test result on file or are willing to get one - You are proficient in English (cognitive tests are in English) **You may NOT be eligible if...** - You have moderate or severe Alzheimer's (MMSE below 22) - You do not have evidence of amyloid changes in the brain - You are not able to complete English-language cognitive testing Talk to your doctor to see if this trial is right for you.